Elizabeth Acuna: The instructions and advice that I’ve been given regarding dupilumab, and the treatment schedule, have been really great. Obviously, it’s through the study protocol. So, I’ve been given some great advice about how to inject the medicine—following which areas to inject, which sites, and how to rotate that around. On top of that, calling in adverse reactions if I have anything. I make sure I call those in. The third thing is a weekly log, so I call in and report how I’m feeling. It’s a scale, 1-10, on certain things like how I’m feeling this week compared to other weeks. It really keeps a nice pulse on things. I definitely have some good follow-up and instructions where I feel very safe and very comfortable with the medication.
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
April 17th 2025Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at diagnosis, resulting in delayed chemotherapy initiation and highlighting the need for more inclusive guidelines.
Read More
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More